๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Announcement: health economics letters


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
19 KB
Volume
9
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Health economics: an evolving paradigm
โœ Alan Maynard; Panos Kanavos ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB
Multilevel models and health economics
โœ Nigel Rice; Andrew Jones ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB

Multilevel analyses have become an accepted statistical technique in the field of education where over the past decade or so the methods have been developed to explore the relationships between pupil characteristics and the characteristics of the schools they attend. More recently, widespread use ha

A nice challenge for health economics
โœ John Hutton; Alan Maynard ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB
Health Economics E-mail Discussion Lists
โœ Bruce Hollingsworth ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 23 KB

Recently there has been a spate of new health economics related electronic mailing (e-mail) lists. The setting up of these lists has been a response to the increased awareness of the usefulness of e-mail as a forum for discussion and information exchange. As such, it would seem timely to step back a

Health economics research and antitrust
โœ Louis Silvia; Robert F. Leibenluft ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 42 KB ๐Ÿ‘ 1 views

Antitrust analysis is typically very fact intensive, and enforcement outcomes always depend on the circumstances in particular markets. Nonetheless, there are issues of broad antitrust significance, and it is in these areas that health economics can make important contributions to enforcement policy

Health care economics of cancer in the e
โœ Joseph S. Bailes ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB ๐Ÿ‘ 2 views

Changing economic circumstances have brought increased pressure to bear on the traditional revenue sources of oncologists. Practice standards and settings are being challenged to generate cost savings both for third-party payers and for oncology practices. Add to this the growing number of patients